Fiber2026-10

The Gut-Insulin Axis in Polycystic Ovary Syndrome: A Narrative Review of Gut Dysbiosis, Inflammation, and Emerging Therapeutic Strategies.

Shruti, Bala Kanchan — Reproductive sciences (Thousand Oaks, Calif.)

Summary

Polycystic Ovary Syndrome (PCOS) is a common condition affecting women, often involving insulin resistance. Recent research highlights a strong connection between our gut health, specifically the balance of gut bacteria, and the development of PCOS symptoms. This connection, called the gut-insulin axis, suggests that managing gut health through diet, including fiber, could be a key part of future PCOS treatments.

AI-generated summary — read the original

Key points

Polycystic Ovary Syndrome (PCOS) is a common condition often linked to insulin resistance.
An imbalance in gut bacteria, known as dysbiosis, appears to play a significant role in PCOS development and symptoms.
This gut-insulin connection suggests that managing gut health could be a new approach to PCOS treatment.
Dietary fiber and other microbiome-focused strategies are being investigated for their potential benefits.

What the study looked at

What question did this study ask? This paper explored the intricate relationship between our gut health, insulin regulation, and Polycystic Ovary Syndrome (PCOS). It aimed to understand how an imbalance in gut bacteria contributes to PCOS symptoms like insulin resistance and inflammation, and what new treatment approaches might emerge from this understanding. How was it studied? This was a "narrative review," meaning the authors did not conduct a new experiment. Instead, they thoroughly examined and summarized a wide range of existing scientific studies and research papers on PCOS, gut dysbiosis, inflammation, and related therapeutic strategies. They synthesized current knowledge to provide a comprehensive overview of the field. What did it find? The review highlighted that an unhealthy balance of gut bacteria, known as dysbiosis, can disrupt the gut lining, leading to chronic low-grade inflammation and increased insulin resistance—both central to PCOS. It detailed how gut bacteria influence various metabolic and hormonal pathways. The paper concluded that targeting the gut microbiome through interventions like dietary fiber, probiotics, or even more advanced therapies could offer promising, personalized strategies to improve metabolic, endocrine, and reproductive health in women with PCOS.

Dietary takeaway

This review suggests that what we eat significantly impacts our gut bacteria, which in turn can influence conditions like PCOS. Increasing your intake of dietary fiber through whole grains, fruits, vegetables, and legumes can help foster a healthier gut microbiome. While promising, remember that this is a review of existing research, and individual studies are just one piece of the puzzle; always consult a healthcare professional for personalized advice.

Abstract

Polycystic ovary syndrome (PCOS) is a complicated, endocrine-endemic disorder with a prevalence rate of 8-13% in reproductive-age women in the world, which manifests through insulin resistance, hyperandrogenism, and reproductive dysfunction. Despite its high global prevalence, existing therapeutic interventions focus predominantly on symptom management rather than targeting the heterogeneous and multifactorial pathophysiology of the syndrome. Intestinal barrier integrity is destroyed by dysbiosis of the gut microbiota and induces endotoxemia and chronic low-grade inflammation through signalling pathways, such as LPS-TLR4-NF-kB signalling, which contribute to increased insulin resistance and androgen excess. These mechanistic pathways we dissect include changes in short-chain fatty acids (SCFAs), bile acid metabolism, involvement of FXR and TGR5 receptors, neuroendocrine regulation of the gut-brain axis, and microbial metabolites (tryptophan and agmatine), which altogether alter metabolic and reproductive abnormalities in PCOS. The preclinical evidence in the area of fecal microbiota transplantation proves the causal component of microbiota imbalance in the phenotype of PCOS. Dietary interventions that have been reviewed are fiber and resistant starch modulation, probiotics, prebiotics, synbiotics, fecal microbiota transplantation, and pharmacotherapies like metformin, which also alter the microbiome. They are heading towards individualized microbiome-based therapies and diagnostics, aided by artificial intelligence and standardized biomarkers. This review explains the emerging role of the gut-insulin axis as an important factor in the pathogenesis of PCOS and uses a novel way of combining them as a radical intervention for personalized and innovative PCOS treatment, which has the potential to enhance metabolic and endocrine health, as well as reproductive outcomes.

View on PubMed →DOI: 10.1007/s43032-026-02220-6